The European Commission has approved Ipsen’s oral therapy Ojemda (tovorafenib) to treat certain children with…
Articles by Marisa Horak, MS
In an early clinical trial, people with certain advanced or treatment-resistant gynecological cancers showed strong responses to the experimental…
The U.S. Food and Drug Administration (FDA) has granted fast track status to Opna Bio‘s OPN-6602 as…
AML World Awareness Day, an annual effort to educate people about acute myeloid leukemia (AML), is coming up on…
Most people with previously-treated metastatic pancreatic cancer lived for at least one year after receiving the oral therapy candidate…
The U.S. Food and Drug Administration (FDA) has granted breakthrough therapy designation to plixorafenib as a potential treatment for adults…
A new regimen using the immunotherapy Keytruda (pembrolizumab) has been approved in the European Union for use by certain…
The U.S. Food and Drug Administration (FDA) has agreed to review an application from Telix Pharmaceuticals seeking approval of…
The U.S. Food and Drug Administration (FDA) has given the green light for a first-in-human clinical trial to test a…
A new CAR T-cell therapy designed to treat gastric (stomach) and pancreatic cancers will soon be available to patients in…